# AbbVie Inc. (ABBV) — Q2-2024 Earnings Results

**Report date:** 2024-07-25 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2024

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 3.38%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.65 | N/A | +3.03% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

AbbVie reported better-than-expected earnings per share, which led to a positive stock reaction, with shares rising by 3.38%. The lack of revenue data and management commentary leaves some uncertainty about the overall performance and future outlook. Investors may be encouraged by the EPS beat but will likely await further details in future reports.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2024_